Salt Lake City, UT, United States of America

Terry Morgan

This inventor holds 2 USPTO granted patents. Top assignee: University of Utah Research Foundation. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Terry Morgan. Retrieved from https://idiyas.com/inventor/terry-morgan-80w5wltv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2002-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Terry Morgan

Introduction

Terry Morgan is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of drug screening and diagnosis, particularly in relation to hypertension. With a total of 2 patents, his work has the potential to impact medical practices and improve patient outcomes.

Latest Patents

Terry Morgan's latest patents focus on drug screening and diagnosis based on the paracrine tubular renin-angiotensin system. The first patent describes a method for screening drugs intended for treating hypertension, utilizing the tubular renin-angiotensinogen system identified by his research. Additionally, this invention provides a method to diagnose sodium status and sensitivity in individuals by measuring urinary angiotensinogen or angiotensin-I. This innovative approach could lead to more effective treatments for hypertension and better management of related health issues.

Career Highlights

Terry Morgan is affiliated with the University of Utah Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving healthcare through scientific discovery and practical applications.

Collaborations

Terry has collaborated with esteemed colleagues, including Andreas Rohrwasser and Jean-Marc Lalouel. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Terry Morgan's contributions to drug screening and diagnosis represent a significant advancement in the medical field. His innovative methods have the potential to transform the way hypertension is treated and diagnosed, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…